eMedicine Specialties > Clinical Procedures > none

Dermabrasion

Author: Christopher B Harmon, MD, Clinical Instructor of Dermatology, Department of Dermatology, University of Alabama at Birmingham
Coauthor(s): Chad L Prather, MD, Clinical Assistant Professor, Department of Dermatology, Louisiana State University Health Sciences Center
Contributor Information and Disclosures

Updated: Apr 3, 2009

Introduction

Dermabrasion involves mechanically resurfacing the skin with an abrasive tip driven by a high-speed rotary hand engine. Either a wire brush or a diamond fraise may be used as the abrading tip to create an open wound that heals by secondary intention. An irregular or scarred cutaneous surface may be surgically abraded in order to achieve a more regular plane, or a more gradual transition between different planes, thereby improving skin contour.1

History of the Procedure

Kurtin2 presented the first series of patients who underwent dermabrasion to Mount Sinai Hospital in 1953. Kurtin described the use of high-speed rotary abraders, intraoperative freezing, and a variety of abrasive end pieces. Publications by Orentreich and Orentreich and Burks and Thomas further refined Kurtin's technique.3,4,5 Alt has expertly promoted the use of the diamond fraise,6 while Yarborough has encouraged application of the wire brush.7

The development of antiviral medications, semipermeable dressings, tumescent anesthesia, and cryoanesthesia has advanced the technique of dermabrasion as well as other resurfacing surgeries, such as chemical peeling, ablative laser resurfacing (see Cutaneous Laser Resurfacing, Carbon Dioxide and Cutaneous Laser Resurfacing, Erbium-YAG), nonablative laser resurfacing, and microdermabrasion. A comprehensive understanding of the advantages and the disadvantages of each of these resurfacing procedures is necessary to achieve optimal surgical results in patients who undergo resurfacing surgery.

Presentation

Careful examination of the skin lesion or defect and a detailed history is paramount in the evaluation of a patient for dermabrasion.

  • As part of the preoperative examination, meticulous attention should be given to the patient's skin type.
    • Midrange skin types (III-IV) are more likely to become transiently hyperpigmented 4-8 weeks after surgery and hypopigmented 12-18 months after surgery.
    • Lighter skin types (I-II) and the darkest skin type (VI) are less likely to heal with permanent discoloration.
    • Examine the patient's earlobes and sternum for areas of keloids or hypertrophic scarring. For patients with a history of keloid formation, a test spot is recommended prior to any full-face resurfacing or ablation of large nonfacial areas. Likewise, a history of koebnerizing or pathergic conditions, such as psoriasis, lichen planus, or pyoderma gangrenosum, may require test sites.
    • Note the presence of facial telangiectasias and variation of pigment between the cosmetic units of the face.
  • Once the patient's skin and defects have been closely examined, an in-depth consultation should follow.
    • The most important aspect of preoperative consultation is listening closely to the patient's specific motivation for undergoing dermabrasion. Identifying this goal and establishing realistic outcome expectations is critical.
    • Reviewing before and after photographs helps establish the expected measure of improvement. The anticipated outcome for patients undergoing resurfacing should be partial improvement (35-50%), rather than complete eradication of the treated defects.
  • Clinical photographs and a detailed discussion of the preoperative regimen, the proceedings on the day of surgery, and postoperative wound care are helpful in preparing patients undergoing dermabrasion.
  • Lastly, take a standardized set of preoperative photographs of each patient. These photographs can be taken directly in front of the patient at 45° angles (right and left sides) and at 90° angles (right and left sides). Close-up photographs of the defects are also helpful. For details on technique and equipment, see eMedicine article Digital Photography.

Indications

The most common indications for dermabrasion are desired improvement of acne scars, traumatic and surgical scars, rhinophyma, deep rhytides, and partial-thickness Mohs defects. However, dermabrasion has also been described for improvement of actinic keratoses,8 seborrheic keratoses, angiofibromas, syringomas, solar elastosis, epidermal nevi, and tattoo removal.

With regard to acne scarring, even in the era of laser devices, fractionated delivery approaches, and noninvasive tissue-tightening procedures, dermabrasion remains an important tool in the combination approach to the improvement of cystic acne scarring. While the shallow and wide, undulating, or "rolling-type" acne scars are better treated with subcision, dermal grafts, fillers, or fractionated laser devices, the slightly deeper and narrower "boxcar-type" acne scars that demonstrate step-off vertical borders respond best to mechanical dermabrasion. Additionally, the deepest and narrowest "icepick-type" acne scars respond best to dermabrasion subsequent to punch excisions, punch grafts, or trichloroacetic acid cross-destruction.9,10

For traumatic and surgical scars, the thickness, contour, and overall appearance is routinely improved with postoperative dermabrasion. Also known as scarabrasion, this procedure is best performed 6-8 weeks after the initial surgery or wounding event. When performed during this 6- to 8-week window, the late proliferative and early remodeling phases of wound healing are interrupted and partially reset, resulting in an improved final cosmetic result.

While several modalities, including wire loop electrosurgery and carbon dioxide laser resurfacing, have been described for the treatment of rhinophyma, dermabrasion remains unmatched in the operator’s ability to reestablish the complex contour of the many cosmetic subunits of the nose. Furthermore, although carbon dioxide resurfacing, Er:YAG resurfacing, and deep chemical peels may improve facial rhytides, dermabrasion proves as efficacious or more efficacious at removal of both fine and moderate facial rhytides, with a slightly lower risk of permanent hypopigmentation.11,12,13

Finally, dermabrasion has proven to be an incredibly useful technique in the armamentarium of the Mohs surgeon (also see Mohs Micrographic Surgery). Thin carcinomas in cosmetically sensitive or high-risk areas can often be completely removed with a shallow Mohs layer to the level of the superficial reticular dermis. After clearance, these partial-thickness defects, particularly on the nose and scalp, may lend themselves to healing by second intention rather than primary closure, yet with slightly increased risk of an evident contour discrepancy or sharp pigmentary transition. Dermabrasion of the edges surrounding the partial-thickness Mohs defect greatly improves the final contour by replacing the steeply beveled wound edge with a more gradual slope. Additionally, dermabrading the remainder of an involved cosmetic subunit of the nose results in a less obvious scar by placing the pigmentary demarcation lines at the less perceptible subunit boundaries.

Contraindications

In addition to careful examination of the skin lesion or defect, a detailed history is paramount in the evaluation of the patient for dermabrasion. For example, do not perform dermabrasion for 6-12 months following isotretinoin therapy. Delayed reepithelialization and hypertrophic scarring have been reported in patients who underwent dermabrasion during or shortly after isotretinoin therapy. This complication is believed to be related to the effect of the isotretinoin molecule on epithelial cells and fibroblasts. Postpone dermabrasive surgery in patients with active herpetic lesions.14,15

Bleeding disorders and immunosuppression may cause delayed healing and an increased risk for postoperative infection.

Yarborough demonstrated that surgical and traumatic scars respond best to dermabrasion performed 6-8 weeks during the interval following incision or injury.16 In contrast, do not perform dermabrasion on overlying skin for at least 6 months following certain surgical procedures that involve extensive undermining, such as face lifts or brow lifts, to allow reestablishment of the underlying vascular bed.

As compared to fully ablative resurfacing with the carbon dioxide  and Er:YAG lasers, dermabrasion demonstrates similar or greater efficacy for the treatment of scars, rhytides, and precancerous lesions, with less postoperative erythema and more rapid reepithelialization. While newer, fractionated delivery protocols result in even less erythema and quicker reepithelialization than dermabrasion, their efficacy for the improvement of scars, rhytides, and precancerous lesions does not currently match that seen with mechanical dermabrasion. Dermabrasion has also been shown to be more efficacious than 5-fluorouracil for the treatment of actinic keratoses.

The major disadvantage of dermabrasion compared with the above-mentioned modalities is that it is much more operator dependent. Unlike laser and light devices, the depth of penetration is not preprogrammed. Successful treatment relies not only on the physician’s knowledge of the modality and application settings, but also on his or her skilled execution. In the novice’s hands, dermabrasion exhibits a narrower window or buffer between effective treatment depth and inappropriate scarring depth. However, this is quickly overcome with experience.

More on Dermabrasion

Overview: Dermabrasion
Workup: Dermabrasion
Treatment: Dermabrasion
Follow-up: Dermabrasion
Multimedia: Dermabrasion
References

References

  1. Campbel RM, Harmon CB. Dermabrasion in our practice. Journal of Drugs in Dermatology. 2008;7:124-128.

  2. Kurtin A. Corrective surgical planing of skin; new technique for treatment of acne scars and other skin defects. AMA Arch Derm Syphilol. Oct 1953;68(4):389-97. [Medline].

  3. Burks JW, Thomas CC. Wire Brush Surgery. Charles C. Thomas: Springfield, Ill; 1956.

  4. Orentreich D, Orentreich N. Acne scar revision update. Dermatol Clin. Apr 1987;5(2):359-68. [Medline].

  5. Orentreich DS, Orentreich N. Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg. Jun 1995;21(6):543-9. [Medline].

  6. Alt TH. Technical aids for dermabrasion. J Dermatol Surg Oncol. Jun 1987;13(6):638-48. [Medline].

  7. Yarborough JM Jr. Dermabrasion by wire brush. J Dermatol Surg Oncol. Jun 1987;13(6):610-5. [Medline].

  8. Coleman WP 3rd, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg. Jan 1996;22(1):17-21. [Medline].

  9. Johnson WC. Treatment of pitted scars: punch transplant technique. J Dermatol Surg Oncol. Mar 1986;12(3):260-5. [Medline].

  10. Solotoff SA. Treatment for pitted acne scarring--postauricular punch grafts followed by dermabrasion. J Dermatol Surg Oncol. Oct 1986;12(10):1079-84. [Medline].

  11. Goldberg DJ, Cutler KB. Nonablative treatment of rhytids with intense pulsed light. Lasers Surg Med. 2000;26(2):196-200. [Medline].

  12. Kamer FM, Lefkoff LA. Injectable collagen, chemical peeling and dermabrasion as an adjunct to rhytidectomy. Facial Plast Surg. Jan 1992;8(1):89-92. [Medline].

  13. Menaker GM, Wrone DA, Williams RM, Moy RL. Treatment of facial rhytids with a nonablative laser: a clinical and histologic study. Dermatol Surg. Jun 1999;25(6):440-4. [Medline].

  14. Katz BE, Mac Farlane DF. Atypical facial scarring after isotretinoin therapy in a patient with previous dermabrasion. J Am Acad Dermatol. May 1994;30(5 Pt 2):852-3. [Medline].

  15. Rubenstein R, Roenigk HH Jr, Stegman SJ, Hanke CW. Atypical keloids after dermabrasion of patients taking isotretinoin. J Am Acad Dermatol. Aug 1986;15(2 Pt 1):280-5. [Medline].

  16. Yarborough JM Jr. Ablation of facial scars by programmed dermabrasion. J Dermatol Surg Oncol. Mar 1988;14(3):292-4. [Medline].

  17. Mandy SH. Tretinoin in the preoperative and postoperative management of dermabrasion. J Am Acad Dermatol. Oct 1986;15(4 Pt 2):878-9, 888-9. [Medline].

  18. Hanke CW, O'Brian JJ. A histologic evaluation of the effects of skin refrigerants in an animal model. J Dermatol Surg Oncol. Jun 1987;13(6):664-9. [Medline].

  19. Hanke CW, O'Brian JJ, Solow EB. Laboratory evaluation of skin refrigerants used in dermabrasion. J Dermatol Surg Oncol. Jan 1985;11(1):45-9. [Medline].

  20. Roenigk HH Jr, Pinski JB, Robinson JK, Hanke CW. Acne, retinoids, and dermabrasion. J Dermatol Surg Oncol. Apr 1985;11(4):396-8. [Medline].

  21. Sabini P. Classifying, diagnosing, and treating the complications of resurfacing the facial skin. Facial Plast Surg Clin North Am. Aug 2004;12(3):357-61, vi. [Medline].

  22. Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, Geronemus RG. The safety and efficacy of the 309 nm excimer laser for pigment correction of hypopigmented scars and striae alba. Archives of Dermatology. 2004;140:955-960.

  23. Fulton JE Jr, Rahimi AD, Mansoor S, Helton P, Shitabata P. The treatment of hypopigmentation after skin resurfacing. Dermatol Surg. Jan 2004;30(1):95-101. [Medline].

  24. Grimes PE, Bhawan J, Kim J, Chiu M, Lask G. Laser resurfacing-induced hypopigmentation: histologic alterations and repigmentation with topical photochemotherapy. Dermatol Surg. Jun 2001;27(6):515-20. [Medline].

  25. Alster TS, West TB. Resurfacing of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser. Dermatol Surg. Feb 1996;22(2):151-4; discussion 154-5. [Medline].

  26. Alt TH, Goodman GJ, Coleman WP III, et al. Dermabrasion. In: Coleman WP III, Hanke CW, Alt TH, Asken S, eds. Cosmetic Surgery of the Skin. Vol 85. 2nd ed. St Louis, Mo: Mosby; 1997:112-151.

  27. Bernard RW, Beran SJ, Rusin L. Microdermabrasion in clinical practice. Clin Plast Surg. Oct 2000;27(4):571-7. [Medline].

  28. Brody H, Lawrence N, Alt TH. Chemical peeling. In: Coleman WP III, Hanke CW, Alt TH, Asken S, eds. Cosmetic Surgery of the Skin. Vol 85. 2nd ed. St Louis, Mo: Mosby; 1997:111.

  29. Coleman WP 3rd, Klein JA. Use of the tumescent technique for scalp surgery, dermabrasion, and soft tissue reconstruction. J Dermatol Surg Oncol. Feb 1992;18(2):130-5. [Medline].

  30. Fulton JE Jr. Dermabrasion, chemabrasion, and laserabrasion. Historical perspectives, modern dermabrasion techniques, and future trends. Dermatol Surg. Jul 1996;22(7):619-28. [Medline].

  31. Gold MH. Dermabrasion in dermatology. Am J Clin Dermatol. 2003;4(7):467-71. [Medline].

  32. Goldberg DJ. Nonablative resurfacing. Clin Plast Surg. Apr 2000;27(2):287-92, xi. [Medline].

  33. Goodman G. Dermabrasion using tumescent anesthesia. J Dermatol Surg Oncol. Dec 1994;20(12):802-7. [Medline].

  34. Hanke CW, Roenigk HH Jr, Pinksi JB. Complications of dermabrasion resulting from excessively cold skin refrigeration. J Dermatol Surg Oncol. Sep 1985;11(9):896-900. [Medline].

  35. Kirsner RS. Wound Healing. In: Bolognia JL. Dermatology. 2nd ed. Spain: Elsevier; 2008:2147-2158.

  36. Lloyd JR. The use of microdermabrasion for acne: a pilot study. Dermatol Surg. Apr 2001;27(4):329-31. [Medline].

  37. Murphy GF. Histology of the Skin. In: Elder D. Lever's Histopathology of teh Skin. Philadelphia: Lippincott; 1997:42-43.

  38. Pinski JB. Dressings for dermabrasion: new aspects. J Dermatol Surg Oncol. Jun 1987;13(6):673-7. [Medline].

  39. Robbins N. Dr. Abner Kurtin, father of ambulatory dermabrasion. J Dermatol Surg Oncol. Apr 1988;14(4):425-31. [Medline].

  40. Roenigk HH Jr. Dermabrasion for miscellaneous cutaneous lesions (exclusive of scarring from acne). J Dermatol Surg Oncol. May-Jun 1977;3(3):322-8. [Medline].

  41. Stegman SJ, et al. Dermabrasion in cosmetic dermatologic surgery. Cosmetic Dermatologic Surgery. 1990;Year Book:59.

  42. Trelles MA, Allones I, Luna R. Facial rejuvenation with a nonablative 1320 nm Nd:YAG laser: a preliminary clinical and histologic evaluation. Dermatol Surg. Feb 2001;27(2):111-6. [Medline].

  43. Tsai RY, Wang CN, Chan HL. Aluminum oxide crystal microdermabrasion. A new technique for treating facial scarring. Dermatol Surg. Jun 1995;21(6):539-42. [Medline].

Further Reading

Keywords

dermabrasion, cutaneous resurfacing, resurfacing surgery, dermabrasive resurfacing, skin resurfacing

Contributor Information and Disclosures

Author

Christopher B Harmon, MD, Clinical Instructor of Dermatology, Department of Dermatology, University of Alabama at Birmingham
Christopher B Harmon, MD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Medical Association, American Society for Laser Medicine and Surgery, and Medical Association of the State of Alabama
Disclosure: Nothing to disclose.

Coauthor(s)

Chad L Prather, MD, Clinical Assistant Professor, Department of Dermatology, Louisiana State University Health Sciences Center
Chad L Prather, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, Dermatology Foundation, and Louisiana State Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Désirée Ratner, MD, Director of Dermatologic Surgery, Professor of Clinical Dermatology, Department of Dermatology, Columbia University Medical Center, New York Presbyterian Hospital
Désirée Ratner, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Medical Association, American Society for Dermatologic Surgery, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

John G Albertini, MD, Consulting Staff, Dermatologic Surgery, The Skin Surgery Center; Program Director, ACGME accredited Fellowship in Procedural Dermatology
John G Albertini, MD is a member of the following medical societies: American Academy of Dermatology and American College of Mohs Micrographic Surgery and Cutaneous Oncology
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.